Cochrane · systematic review · CD007967

Acetylcholinesterase inhibitors for schizophrenia

Singh, J, Kour, K, Jayaram, MB · Cochrane Database of Systematic Reviews · 2012 · Cochrane Library

SchizophreniaAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
0
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 7 · 100%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Comparison

Population: schizophrenia
7 questions
OutcomeEffectEvidenceStatus / GRADE
Global effect: 1a. Medium‐term ‐ Average end point score on various outcomes ‐ CGI‐severity (low = favourable) (
no estimate extracted1 study · 11 participantsUngraded
Leaving the study early ‐ Adverse event: Short‐term
RR 1.91 [0.8, 4.61]6 studies · 428 participantsUngraded
Mental state: 1b. Average end point score on various outcomes‐PANSS (medium‐term) ‐ Medium‐term ‐ PANSS negative end point score (low = favourable)
no estimate extracted2 studies · 31 participantsUngraded
Mental state: 1b.Average end point score on various outcomes‐PANSS (medium‐term) ‐ Medium term ‐ PANSS general psychopathology end point score (low = favourable)
no estimate extracted2 studies · 31 participantsUngraded
Cognitive function: 3. Short‐term ‐ Average end point score on various subscales of WAIS III (high = favourable) ‐ Digit symbol score
no estimate extracted1 study · 73 participantsUngraded
Cognitive function: 4. Short‐term ‐ Average end point score on various subscales of HVLT (high = favourable) ‐ Recognition
no estimate extracted2 studies · 48 participantsUngraded
Adverse event: 11a. Short‐term ‐ Average end point score on EPSEs scale (low = favourable) ‐ AIMS
no estimate extracted1 study · 35 participantsUngraded